D W Gil, C V Cheevers, J E Donello
Index: Br. J. Pharmacol. 153(4) , 769-74, (2008)
Full Text: HTML
The most common preclinical models of neuropathic pain involve surgical ligation of sensory nerves, which is especially difficult in mice. Transient models of chemically sensitized allodynia are potentially useful for rapidly characterizing the analgesic profile of compounds and conducting mechanistic studies.Increasing doses of NMDA, sulprostone (an EP1/EP3 prostaglandin receptor agonist) or phenylephrine (an alpha (1) adrenoceptor agonist) were injected intrathecally (i.t.) or i.p., and animals were subsequently assessed for allodynia. The effects of receptor antagonists and analgesic compounds on allodynia were also assessed.A comparison of total body doses that cause allodynia following spinal or systemic administration indicated that NMDA induces allodynia in the spinal cord while sulprostone and phenylephrine act through a peripheral mechanism. Inhibition of the allodynia with receptor antagonists indicated that each agent induces allodynia by a distinct mechanism. The three models were benchmarked using compounds known to be active in neuropathic pain patients and nerve injury animal models, including gabapentin, amitriptyline and clonidine.These transient allodynia models are a useful addition to the toolbox of preclinical pain models. They are simple, rapid and reproducible, and will be especially useful for characterizing the pain phenotype of knockout mice.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
5-Methylurapidil
CAS:34661-85-3 |
C21H32ClN5O3 |
Cell membrane chromatography competitive binding analysis fo...
2011-07-01 [Anal. Bioanal. Chem 400(10) , 3625-33, (2011)] |
Influence of high dietary sodium intake on the functional su...
2009-01-01 [Auton. Autacoid Pharmacol. 29(1-2) , 25-31, (2009)] |
Alpha-1A adrenergic receptor activation increases inhibitory...
2009-04-01 [Epilepsy Res. 84(2-3) , 97-109, (2009)] |
Pharmacological characterization of alpha1- and beta-adrener...
2006-02-01 [Arch. Physiol. Biochem. 112(1) , 23-30, (2006)] |
Influence of cisplatin-induced renal failure on the alpha(1)...
2007-08-13 [Eur. J. Pharmacol. 569(1-2) , 110-8, (2007)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved